Compound Danshen injection improves endotoxin-induced microcirculatory disturbance in rat mesentery

Jing-Yan Han1, Yoshinori Horie, Soichiro Miura

  • 1Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Beijing 100083, China. kan@chuigaku.co.jp

Abstract

Insights

Compound Danshen injection effectively treats lipopolysaccharide-induced microcirculatory dysfunction in rats. It reduces inflammation and improves blood flow by targeting multiple pathways.

Area of Science:

  • Pharmacology
  • Microcirculation Research
  • Inflammation Studies

Background:

  • Lipopolysaccharide (LPS) induces significant mesenteric microcirculatory dysfunction.
  • This dysfunction involves increased leukocyte adhesion, free radical production, and vascular leakage.
  • Understanding the mechanisms behind LPS-induced injury is crucial for developing effective treatments.

Purpose of the Study:

  • To evaluate the therapeutic effects of compound Danshen injection on LPS-induced microcirculatory disturbances in rats.
  • To investigate the underlying mechanisms of action of compound Danshen injection.
  • To assess the impact on leukocyte behavior, vascular permeability, and inflammatory mediators.

Main Methods:

  • Utilized an inverted intravital microscope and high-speed video system to observe rat mesenteric microcirculation.
  • Administered continuous LPS infusion to induce microcirculatory dysfunction.
  • Quantified leukocyte rolling, adhesion, emigration, free radical production, albumin leakage, and mast cell degranulation.
  • Employed flow cytometry for in vitro analysis of adhesion molecule expression (CD11b/CD18, ICAM-1) and free radical production in neutrophils and HUVECs.

Main Results:

  • LPS infusion significantly increased leukocyte rolling and adhesion, free radical production, albumin efflux, and mast cell degranulation.
  • Compound Danshen injection attenuated most LPS-induced microcirculatory changes, including albumin efflux and mast cell degranulation.
  • In vitro studies showed compound Danshen injection reduced LPS-induced expression of CD11b/CD18, ICAM-1, and free radical production.

Conclusions:

  • Compound Danshen injection demonstrates significant efficacy in ameliorating LPS-induced mesenteric microcirculatory dysfunction.
  • The drug exhibits multi-targeting potential, suggesting a broad mechanism of action.
  • These findings support compound Danshen injection as a promising therapeutic agent for microcirculatory disturbances.

Related Concept Videos